The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes

被引:10
作者
Walgren, JE [1 ]
Kurtz, DT [1 ]
McMillan, JM [1 ]
机构
[1] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA
关键词
cell proliferation; dichloroacetate; human hepatocytes; peroxisome proliferation; trichloroethylene; trichloroacetate;
D O I
10.1023/A:1007638227821
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dichloroacetate (DCA) and trichloroacetate (TCA) are metabolites of the environmental contaminant trichloroethylene (TCE) that are thought to be responsible for its hepatocarcinogenicity in B6C3F(1) mice. TCA and DCA induce peroxisomal proliferation and are mitogenic in rodent liver. The susceptibility of humans to TCA- and DCA-induced hepatocarcinogenesis is unknown. The current studies were aimed at using both primary and long-term human hepatocyte cultures to study the effects of TCA, DCA, and a potent peroxisome proliferator, WY-14,643, on peroxisomal activity and DNA synthesis in human hepatocytes. Peroxisome proliferation, as assessed by palmitoyl-CoA oxidation activity, was below the limit of detection in all human cell lines tested. However, the human cell lines did display small but significant increases in CYP450 4A11 levels following treatment with WY-14,643 (0.1 mmol/L), indicting that the CYP 4A11 gene may be regulated by peroxisome proliferator-activated receptor alpha in humans. Similarly to their effect in rodent hepatocyte cultures, TCA and DCA were not complete mitogens in human hepatocyte cultures. In fact, DNA synthesis tended to be significantly decreased following treatment of the cells with WY-14,643, TCA, or DCA. In contrast to rodent hepatocyte responses, TCA and DCA did not increase palmitoyl-CoA oxidation and caused a decrease in DNA synthesis in human hepatocyte cultures, suggesting that humans may not be susceptible to TCA- and DCA-induced hepatocarcinogenesis.
引用
收藏
页码:257 / 273
页数:17
相关论文
共 64 条
[1]  
[Anonymous], 1997, AG TOX SUBST DIS REG
[2]   CANCER INCIDENCE AMONG FINNISH WORKERS EXPOSED TO HALOGENATED HYDROCARBONS [J].
ANTTILA, A ;
PUKKALA, E ;
SALLMEN, M ;
HERNBERG, S ;
HEMMINKI, K .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1995, 37 (07) :797-806
[3]  
AXELSON O, 1994, J OCCUP ENVIRON MED, V36, P556
[4]   DELAYED-EFFECTS OF CIPROFIBRATE ON RAT-LIVER PEROXISOMAL PROPERTIES AND PROTOONCOGENE EXPRESSION [J].
BARDOT, O ;
CLEMENCET, MC ;
CHERKAOUIMALKI, M ;
LATRUFFE, N .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (07) :1001-1006
[5]   HEPATIC PEROXISOME PROLIFERATION IN RODENTS AND ITS SIGNIFICANCE FOR HUMANS [J].
BENTLEY, P ;
CALDER, I ;
ELCOMBE, C ;
GRASSO, P ;
STRINGER, D ;
WIEGAND, HJ .
FOOD AND CHEMICAL TOXICOLOGY, 1993, 31 (11) :857-907
[6]   THE EFFECT OF BECLOBRIC ACID AND CLOFIBRIC ACID ON PEROXISOMAL BETA-OXIDATION AND PEROXISOME PROLIFERATION IN PRIMARY CULTURES OF RAT, MONKEY AND HUMAN HEPATOCYTES [J].
BLAAUBOER, BJ ;
VANHOLSTEIJN, CWM ;
BLEUMINK, R ;
MENNES, WC ;
VANPELT, FNAM ;
YAP, SH ;
VANPELT, JF ;
VANIERSEL, AAJ ;
TIMMERMAN, A ;
SCHMID, BP .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (03) :521-528
[7]   INFLUENCE OF FENOFIBRATE ON CELLULAR AND SUBCELLULAR LIVER STRUCTURE IN HYPERLIPIDEMIC PATIENTS [J].
BLUMCKE, S ;
SCHWARTZKOPFF, W ;
LOBECK, H ;
EDMONDSON, NA ;
PRENTICE, DE ;
BLANE, GF .
ATHEROSCLEROSIS, 1983, 46 (01) :105-116
[8]   DELINEATION OF THE ROLE OF METABOLISM IN THE HEPATOTOXICITY OF TRICHLOROETHYLENE AND PERCHLOROETHYLENE - A DOSE EFFECT STUDY [J].
BUBEN, JA ;
OFLAHERTY, EJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 78 (01) :105-122
[9]   THE ROLE OF DICHLOROACETATE IN THE HEPATOCARCINOGENICITY OF TRICHLOROETHYLENE [J].
BULL, RJ ;
TEMPLIN, M ;
LARSON, JL ;
STEVENS, DK .
TOXICOLOGY LETTERS, 1993, 68 (1-2) :203-211
[10]   LIVER-TUMOR INDUCTION IN B6C3F1 MICE BY DICHLOROACETATE AND TRICHLOROACETATE [J].
BULL, RJ ;
SANCHEZ, IM ;
NELSON, MA ;
LARSON, JL ;
LANSING, AJ .
TOXICOLOGY, 1990, 63 (03) :341-359